Maintenance of remission

The longer-term stage of treatment, aimed at keeping Crohn's quiet once a flare has settled.

Also called: maintaining remission, keeping crohns under control, staying in remission

Related words induction of remission remission maintenance

Topics Medicines

Questions people ask

What are the main treatments for Crohn's disease?

The NHS explains there is no cure yet, but treatments can control symptoms and keep the disease quiet. NICE describes treatment in two stages: bringing a flare under control (often with steroids) and keeping it under control afterwards (for example with immunosuppressants or biologics). Liquid-only diets are an option, especially for children, and surgery may help when only part of the gut is affected or medicines are not working. Your IBD team will tailor the plan to you.

Sources

What do 'flare-up' and 'remission' mean?

Crohn's usually comes and goes. Crohn's & Colitis UK describes remission as a time when Crohn's is well controlled, you feel better and tests show less inflammation, although some symptoms like tiredness may linger. A flare-up (also called a relapse or active disease) is when symptoms return and tests show the gut is inflamed. The NHS says a flare can last from a few days to several months.

Sources

What is Crohn's disease?

Crohn's is a lifelong condition in which parts of the gut become inflamed and ulcerated. It is one of the main types of inflammatory bowel disease (IBD). It can affect any part of the gut from mouth to bottom, but most often the end of the small bowel (ileum) and the colon, and the affected patches can have healthy bowel in between. The NHS says there is no cure yet, but treatment can keep symptoms under control, often for long periods.

Sources

What is 'top-down' treatment and is it better?

Top-down means starting strong treatment, such as a biologic plus an immunosuppressant, soon after diagnosis instead of trying milder medicines first ('step-up'). In the UK PROFILE trial of newly diagnosed adults, 79% on top-down treatment stayed in remission without steroids or surgery for a year, compared with 15% on step-up, with fewer flares and operations. Your team will weigh this up for your own situation.

Source

What is the difference between 'step-up' and 'top-down' treatment?

Step-up means starting with simpler treatments such as steroids and only moving on to stronger medicines if those do not work. Top-down means starting a biologic early, usually infliximab together with an immunomodulator. The UK PROFILE trial found that, in newly diagnosed people with active Crohn's, top-down treatment led to far more steroid-free and surgery-free remission after a year, and fewer hospital stays and complications after five years. The 2025 BSG guideline now suggests early infliximab for moderate to severe Crohn's.

Sources

Where to read more

Crohn's disease: management (NG129)

NICE Guideline May 2019 For professionals

NICE's guideline for the NHS in England on managing Crohn's in children, young people and adults. It covers giving people information and support, treatment to bring Crohn's under control and keep it there, surgery, keeping remission after surgery, checking bone health, and pregnancy. It is about care after diagnosis rather than how Crohn's is diagnosed.

Topics About Crohn's disease Medicines Surgery Monitoring Pregnancy and fertility Children and young people Steroids Immunosuppressants

Jargon explained remission inducing remission maintaining remission osteopenia NICE guideline induce remission maintain remission glucocorticosteroid thiopurine TPMT resection stricture

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease (FORTIFY)

The Lancet Study May 2022 For professionals

The main international trial of risankizumab injections to keep Crohn's under control after a good response to drip treatment. More people who stayed on risankizumab remained in remission and had gut healing than those switched to placebo, and side effects were similar between groups.

Topics Biologics and newer medicines Research

Jargon explained IL-23 maintenance placebo endoscopic response

Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)

Cochrane Systematic review Feb 2019 Patients and professionals

A Cochrane review of 18 trials that tested cutting down or cutting out foods thought to provoke IBD symptoms. The authors found the evidence too weak to say whether any of these diets help bring on or keep remission, and called for better trials. This summary dates from 2019.

Topics Diet and nutrition Research

Jargon explained remission exclusion diet randomised controlled trial

Vedolizumab for induction and maintenance of remission in Crohn's disease

Cochrane Systematic review Jul 2023 Patients and professionals

Pooling several trials, Cochrane found high-certainty evidence that vedolizumab (Entyvio) works better than placebo both for bringing on remission and keeping it. Overall side effects were probably similar to placebo. Head-to-head comparisons with other biologics are still needed.

Topics Biologics and newer medicines Research

Jargon explained high-certainty evidence induction maintenance integrin

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

Gastroenterology Study Jan 2007 Patients and professionals

The main trial behind adalimumab (Humira and its biosimilars) for keeping Crohn's under control. People who improved on adalimumab were much more likely to still be in remission at about a year if they kept taking it (36-41%) than if switched to placebo (12%). Taking it weekly worked no better than every other week.

Topics Biologics and newer medicines

Jargon explained maintenance remission CDAI placebo

Antibiotics for induction and maintenance of remission in Crohn's disease

Cochrane Systematic review Feb 2019 Patients and professionals

Antibiotics may give a small benefit for active Crohn's, but probably not enough to make a real difference for most people. They did not cause more side effects than placebo. Whether they help keep Crohn's in remission is unclear. Note this is about treating the Crohn's itself, not infections or abscesses.

Topics Medicines Research

Jargon explained antibiotic clinically meaningful antibiotics induction maintenance

The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD)

The Lancet Gastroenterology & Hepatology Study Jan 2022 Patients and professionals

A small pilot trial of 44 adults with mild to moderate Crohn's who had not had biologics. The CDED, with or without supplement drinks, put more than half into remission at 6 weeks, and most of them were still in remission at 24 weeks. About a third had a healed bowel lining. The authors say a bigger trial is needed before firm conclusions.

Topics Diet and nutrition

Jargon explained pilot study open-label endoscopic remission

Methotrexate for maintenance of remission in Crohn's disease

Cochrane (via PMC) Systematic review Aug 2014 Patients and professionals

A Cochrane review finding moderate-quality evidence that methotrexate given by injection helps keep Crohn's in remission and appears safe, while low-dose tablets did not appear effective in the trials reviewed. Adding methotrexate to infliximab did not improve remission rates.

Topics Immunosuppressants Research

Jargon explained methotrexate intramuscular maintenance

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

Cochrane Systematic review Oct 2015 Patients and professionals

Cochrane pooled the trials of azathioprine and mercaptopurine for keeping Crohn's quiet. Low-quality evidence suggests azathioprine works better than placebo, but side effects such as pancreatitis, low white cell counts, sickness and infections limit its use. More good-quality trials are needed.

Topics Immunosuppressants Research

Jargon explained thiopurine low-quality evidence adverse event remission placebo systematic review

Search everything for "maintenance of remission"